Physician

Muhammad Fahair Iqbal, MD

According to 2025 Medicare claims, Muhammad Iqbal, MD (NPI: 1659788941) practices hematology/oncology in the Deltona-Daytona Beach-Ormond Beach, FL market, with the plurality of this provider's patient population coming from Flagler, FL. This provider's primary affiliated billing organization is CANCER SPECIALISTS, LLC (NPI: 1528323268; TIN: 455523028) and primary practice location at 32164-2915. Iqbal is affiliated with the Carolinas HealthCare System ACO, LLC (ACO ID: A3675), participating under the MSSP model.

Iqbal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 357 traditional Medicare patients, billed 73,952 HCPCS/CPT codes, and received $924,468 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 1,241 prescription claims across 220 beneficiaries totaling $2,667,269 in drug costs, led by Empaveli (Pegcetacoplan). Open Payments data shows 2 records totaling $31. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $4,841 to $2,667,269. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$462K$924K2021 Medicare payment: $21,102 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $378,333 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $879,365 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $924,468 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021196323$21,102
202240422,482$378,333
202340176,120$879,365
202435773,952$924,468

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.3M$2.7M2015 Drug cost: $4,841 (USD; Tot_Drug_Cst)2016 Drug cost: $1,287 (USD; Tot_Drug_Cst)2017 Drug cost: $2,561 (USD; Tot_Drug_Cst)2018 Drug cost: $454 (USD; Tot_Drug_Cst)2019 Drug cost: $1,153 (USD; Tot_Drug_Cst)2020 Drug cost: $3,109 (USD; Tot_Drug_Cst)2021 Drug cost: $124,186 (USD; Tot_Drug_Cst)2022 Drug cost: $814,825 (USD; Tot_Drug_Cst)2023 Drug cost: $1,766,174 (USD; Tot_Drug_Cst)2024 Drug cost: $2,667,269 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201533117$4,841
20163364$1,287
20171947$2,561
20181122$454
20191736$1,153
20201128$3,109
202161169$124,186
2022131479$814,825
2023204906$1,766,174
20242201,241$2,667,269

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes102106$102
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more113266$97
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more200368$66
36415Insertion of needle into vein for collection of blood sample195861$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count184813$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EmpaveliPegcetacoplan13364$522,428
RevlimidLenalidomide18490$344,226
VerzenioAbemaciclib13364$192,749
LenalidomideLenalidomide12336$167,578
EliquisApixaban674,680$89,723

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$31Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Muhammad Fahair Iqbal, MD?

Tedicare shows public-source Medicare data for Muhammad Fahair Iqbal, MD (NPI 1659788941), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Muhammad Fahair Iqbal, MD have ACO affiliation data?

Muhammad Fahair Iqbal, MD is shown with ACO affiliation data for Carolinas HealthCare System ACO, LLC (MSSP, ACO ID A3675).

What billing organization is linked to Muhammad Fahair Iqbal, MD?

Muhammad Fahair Iqbal, MD is linked to CANCER SPECIALISTS, LLC (billing NPI 1528323268) in the available physician profile data.

Does Muhammad Fahair Iqbal, MD have Open Payments data?

Muhammad Fahair Iqbal, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.